CGON
CG Oncology, Inc.
72.61
-0.03 (-0.04%)
52w low 37.01
80.97 high
81.0% of range
Financial Analysis
| Ratio | Mar 25 | Jun 25 | Sep 25 | Dec 25 | Mar 26 | Jun 26 | Trend |
|---|---|---|---|---|---|---|---|
| Profitability | |||||||
| Gross Margin | -- | -- | 5.3% | -32.2% | -173.5% | -239.2% | |
| Operating Margin | -- | -- | -3,069.0% | -2,097.3% | -6,130.1% | -7,467.7% | |
| EBITDA Margin | -- | -- | -3,044.0% | -2,060.8% | -6,052.4% | -7,394.2% | |
| Net Margin | -- | -- | -2,629.5% | -1,779.0% | -5,558.8% | -6,832.8% | |
| FCF Margin | -- | -- | -2,340.4% | -1,560.0% | -5,286.0% | -4,052.0% | |
| Returns | |||||||
| Return on Equity | -- | -6.2% | -6.4% | -5.5% | -5.5% | -7.7% | |
| Return on Assets | -- | -5.9% | -6.0% | -5.2% | -5.3% | -7.3% | |
| Return on Inv Capital | -- | -5.7% | -5.8% | -5.1% | -4.8% | -6.6% | |
| Liquidity | |||||||
| Current Ratio | -- | 22.15x | 22.79x | 24.63x | 31.30x | 22.22x | |
| Quick Ratio | -- | 22.15x | 22.74x | 24.58x | 31.25x | 22.20x | |
| Cash Ratio | -- | 0.48x | 1.48x | 1.05x | 0.96x | 0.42x | |
| Leverage | |||||||
| Debt / Equity | -- | 0.00x | 0.01x | 0.01x | 0.01x | 0.01x | |
| Equity Multiplier | -- | 1.05x | 1.06x | 1.05x | 1.04x | 1.05x | |
| Efficiency | |||||||
| Asset Turnover | -- | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | |
| Inventory Turnover | -- | -- | 1.05x | 1.96x | 1.98x | 3.91x | |
| Op CF / Net Income | -- | 0.67x | 0.89x | 0.88x | 0.95x | 0.59x | |
| Investment | |||||||
| Capex / Revenue | -- | -- | 5.8% | 0.3% | 28.1% | 40.4% | |
| R&D / Revenue | -- | -- | 1,673.7% | 1,290.2% | 4,037.9% | 4,724.0% | |
| SG&A / Revenue | -- | -- | 1,400.6% | 774.9% | 1,918.7% | 2,504.4% | |
Revenue CAGR
--
Net Income CAGR
--
EPS CAGR
--
FCF CAGR
--
Revenue YoY
+6.8%